Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

pennant group inc - PNTG

PNTG

Close Chg Chg %
29.07 0.44 1.51%

Closed Market

29.51

+0.44 (1.51%)

Volume: 277.01K

Last Updated:

Dec 11, 2025, 4:00 PM EDT

Trade Now

Company Overview: pennant group inc - PNTG

PNTG Key Data

Open

$29.25

 Day Range

29.14 - 29.65

52 Week Range

21.18 - 30.43

 Market Cap

$1.01B

Shares Outstanding

34.59M

 Public Float

32.93M

Beta

1.31

 Rev. Per Employee

N/A

P/E Ratio

38.20

 EPS

$0.77

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

261.30K

  

PNTG Performance

1 Week
 
 1.03%
 
1 Month
 
 18.51%
 
3 Months
 
 15.36%
 
1 Year
 
 1.37%
 
5 Years
 
 -47.91%
 

PNTG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About pennant group inc - PNTG

The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. It operates through the Home Health and Hospice Services, and Senior Living Services segments. The Home Health and Hospice Services segment provides a combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.

PNTG At a Glance

The Pennant Group, Inc.
1675 East Riverside Drive
Eagle, Idaho 83616
Phone 1-208-506-6100 Revenue 695.24M
Industry Medical/Nursing Services Net Income 22.56M
Sector Health Services 2024 Sales Growth 27.592%
Fiscal Year-end 12 / 2025 Employees 7,000
View SEC Filings

PNTG Valuation

P/E Current 38.202
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 37.617
Price to Sales Ratio 1.221
Price to Book Ratio 3.108
Price to Cash Flow Ratio 23.98
Enterprise Value to EBITDA 25.218
Enterprise Value to Sales 1.605
Total Debt to Enterprise Value 0.245

PNTG Efficiency

Revenue/Employee 99,320.00
Income Per Employee 3,222.714
Receivables Turnover 8.551
Total Asset Turnover 1.003

PNTG Liquidity

Current Ratio 1.208
Quick Ratio 1.208
Cash Ratio 0.238

PNTG Profitability

Gross Margin 12.606
Operating Margin 5.486
Pretax Margin 4.512
Net Margin 3.245
Return on Assets 3.253
Return on Equity 10.405
Return on Total Capital 3.983
Return on Invested Capital 4.514

PNTG Capital Structure

Total Debt to Total Equity 93.115
Total Debt to Total Capital 48.217
Total Debt to Total Assets 35.635
Long-Term Debt to Equity 86.408
Long-Term Debt to Total Capital 44.744
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Pennant Group Inc - PNTG

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
439.69M 473.24M 544.89M 695.24M
Sales Growth
+12.47% +7.63% +15.14% +27.59%
Cost of Goods Sold (COGS) incl D&A
398.74M 419.56M 482.99M 607.60M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.78M 4.90M 5.13M 6.12M
Depreciation
4.75M 4.86M 5.12M 6.12M
Amortization of Intangibles
- 33.00K 44.00K 10.00K
COGS Growth
+17.02% +5.22% +15.12% +25.80%
Gross Income
40.95M 53.69M 61.91M 87.64M
Gross Income Growth
-18.45% +31.09% +15.31% +41.57%
Gross Profit Margin
+9.31% +11.34% +11.36% +12.61%
2021 2022 2023 2024 5-year trend
SG&A Expense
34.17M 33.17M 36.19M 49.50M
Research & Development
- - - -
-
Other SG&A
34.17M 33.17M 36.19M 49.50M
SGA Growth
+15.55% -2.92% +9.10% +36.78%
Other Operating Expense
- - - -
-
Unusual Expense
2.09M 808.00K 476.00K 708.00K
EBIT after Unusual Expense
4.70M 19.70M 25.24M 37.43M
Non Operating Income/Expense
(24.00K) (7.00M) 269.00K 889.00K
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.94M 3.82M 5.92M 6.96M
Interest Expense Growth
+56.66% +96.60% +55.24% +17.42%
Gross Interest Expense
1.94M 3.82M 5.92M 6.96M
Interest Capitalized
- - - -
-
Pretax Income
2.73M 8.89M 19.58M 31.37M
Pretax Income Growth
-84.75% +225.71% +120.24% +60.17%
Pretax Margin
+0.62% +1.88% +3.59% +4.51%
Income Tax
582.00K 1.65M 5.67M 7.03M
Income Tax - Current - Domestic
2.33M (47.00K) 1.67M 8.21M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.75M) 1.70M 4.00M (1.19M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.15M 7.24M 13.91M 24.34M
Minority Interest Expense
(548.00K) 600.00K 531.00K 1.78M
Net Income
2.70M 6.64M 13.38M 22.56M
Net Income Growth
-82.88% +146.40% +101.40% +68.61%
Net Margin Growth
+0.61% +1.40% +2.46% +3.24%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.70M 6.64M 13.38M 22.56M
Preferred Dividends
- - - -
-
Net Income Available to Common
2.70M 6.64M 13.38M 22.56M
EPS (Basic)
0.0949 0.2286 0.448 0.7232
EPS (Basic) Growth
-83.10% +140.89% +95.98% +61.43%
Basic Shares Outstanding
28.41M 29.06M 29.86M 31.19M
EPS (Diluted)
0.088 0.2203 0.4431 0.705
EPS (Diluted) Growth
-83.10% +150.34% +101.13% +59.11%
Diluted Shares Outstanding
30.64M 30.16M 30.19M 32.00M
EBITDA
11.57M 25.41M 30.84M 44.26M
EBITDA Growth
-54.31% +119.69% +21.38% +43.49%
EBITDA Margin
+2.63% +5.37% +5.66% +6.37%

Snapshot

Average Recommendation BUY Average Target Price 33.667
Number of Ratings 7 Current Quarters Estimate 0.318
FY Report Date 12 / 2025 Current Year's Estimate 1.151
Last Quarter’s Earnings 0.30 Median PE on CY Estimate N/A
Year Ago Earnings 0.94 Next Fiscal Year Estimate 1.31
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 5 7 7
Mean Estimate 0.32 0.31 1.15 1.31
High Estimates 0.34 0.32 1.18 1.40
Low Estimate 0.27 0.29 1.10 1.23
Coefficient of Variance 7.25 4.44 2.26 4.87

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 5 3
OVERWEIGHT 0 0 0
HOLD 0 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Pennant Group Inc - PNTG

Date Name Shares Transaction Value
Apr 18, 2025 Scott E. Lamb Director 46,935 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 Barry Morgan Smith Director 82,999 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 Christopher R. Christensen Director 136,491 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 John G. Nackel Director 165,065 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 Stephen M. R. Covey Director 34,550 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 JoAnne Stringfield Director 30,940 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 Gregory K. Morris Director 27,800 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 17, 2025 Brent J. Guerisoli Chief Executive Officer 85,973 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 17, 2025 John J. Gochnour Chief Operating Officer 127,964 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 17, 2025 Lynette B. Walbom Chief Financial Officer 2,663 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 17, 2025 Barry Morgan Smith Director 81,099 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $11.35 per share 920,473.65
Jan 17, 2025 Barry Morgan Smith Director 20,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Pennant Group Inc in the News